台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    95.5
  • 漲跌
    ▼2.5
  • 漲幅
    -2.55%
  • 成交量
    1,815
  • 產業
    上櫃 生技醫療類股
  • 319人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
中裕 (4147)籌碼相關-元富-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2700.00196.6095.50-11,878-0.05%
2025/02/26199.1000.0098.0011,8860.05%
2025/02/211105.5000.0098.9011,7270.06%
2025/02/2000.00299.4599.70-21,553-0.13%
2025/02/19195.6000.0095.2011,5100.07%
2025/02/174102.952107.7597.1021,4400.14%
2025/02/14194.30498.6898.90-31,226-0.24%
2025/02/12193.2000.0093.0011,1520.09%
2025/02/1100.00192.5091.70-11,140-0.09%
2025/02/10189.7000.0089.9011,1290.09%
2025/01/2100.00185.0084.50-11,131-0.09%
2025/01/17084.6000.0084.6001,1310.00%
2025/01/13193.1000.0089.9011,1320.09%
2025/01/09187.5000.0087.5011,0140.10%
2025/01/081101.004101.3897.20-3872-0.34%
2025/01/07291.85192.1192.7016490.15%
2025/01/0200.00188.5087.00-1591-0.17%
2024/12/17181.4000.0082.0016250.16%
2024/12/0600.00188.9087.60-1573-0.17%
2024/12/0300.00184.2084.30-1529-0.19%
2024/11/25184.7000.0085.0015430.18%
2024/11/1800.00180.0078.70-1534-0.19%
2024/11/04183.0000.0081.6015790.17%
2024/10/28283.50282.2081.0005840.00%
2024/10/21274.5000.0075.1025590.36%
2024/10/1400.001.174.7174.00-1.1614-0.17%
2024/10/04178.9000.0078.2016290.16%
2024/09/04182.0000.0081.3017420.13%
2024/07/19188.1000.0086.5017270.14%
2024/07/15386.3000.0086.3037470.40%
2024/07/0300.00587.5087.40-5953-0.52%
2024/06/27289.5000.0089.4021,1190.18%
2024/06/261.189.1100.0089.501.11,1230.10%
2024/06/25287.2000.0087.8021,1210.18%
2024/05/1700.00187.8087.70-12,170-0.05%
2024/05/03285.7000.0085.8022,3180.09%
2024/04/26183.00483.1083.00-32,324-0.13%
2024/04/25483.3500.0082.5042,3250.17%
2024/04/2400.00483.7584.80-42,321-0.17%
2024/04/22183.0000.0081.8012,3290.04%
2024/04/19286.8000.0083.1022,3340.09%
2024/04/17388.37289.1087.8012,3560.04%
2024/04/1600.00288.7087.90-22,351-0.09%
2024/04/15492.3500.0090.1042,3420.17%
2024/04/1200.00194.6094.00-12,339-0.04%
2024/04/1000.00194.5093.20-12,339-0.04%
2024/04/0900.00295.7596.20-22,301-0.09%
2024/04/08190.8000.0093.0012,2360.04%
2024/04/03391.4300.0090.6032,1950.14%
2024/04/02189.0000.0088.5012,0880.05%
2024/04/0100.00288.6090.10-22,074-0.10%
2024/03/29687.93488.2087.5022,0530.10%
2024/03/2800.00288.5088.40-22,045-0.10%
2024/03/27287.5000.0088.0022,0400.10%
2024/03/2600.001088.7088.10-102,033-0.49%
2024/03/25188.3000.0087.8012,0270.05%
2024/03/22288.60289.5088.8002,0200.00%
2024/03/21389.4000.0088.6032,0140.15%
2024/03/20690.5300.0089.4062,0020.30%
2024/03/18190.0000.0091.3011,9810.05%
2024/03/1500.00291.2090.10-21,970-0.10%
2024/03/1300.00292.5090.90-21,947-0.10%
2024/03/08397.70496.8096.80-11,865-0.05%
2024/03/051108.5000.00102.5011,7040.06%
2024/03/0400.001108.00109.00-11,641-0.06%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章